These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical significance of electrophysiologic drug testing in the longterm therapy of class I, III and IV antiarrhythmic drugs for recurrent ventricular tachyarrhythmia]. Kasanuki H; Ohnishi S; Amamiya K; Umemura J; Shoda M; Hosoda S Jpn Circ J; 1992; 56 Suppl 5():1458-61. PubMed ID: 1291742 [No Abstract] [Full Text] [Related]
4. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia. van Hemel NM; Kingma JH; Defauw JJ; Hoogteijling-van Dusseldorp E; Kelder JC; Beukema WP; Vermeulen FE Eur Heart J; 1996 Apr; 17(4):564-73. PubMed ID: 8733090 [TBL] [Abstract][Full Text] [Related]
5. [What remains of anti-arrhythmia drugs?]. Lévy S Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1501-5. PubMed ID: 8010849 [TBL] [Abstract][Full Text] [Related]
6. How to prescribe and manage antiarrhythmic drug therapy. Camm AJ; Katritsis D Eur Heart J; 1992 Nov; 13 Suppl F():44-52. PubMed ID: 1478221 [TBL] [Abstract][Full Text] [Related]
7. Clinical approach to antiarrhythmic therapy in patients with ventricular arrhythmia. Reddy CP; Arnett JD J La State Med Soc; 1989 May; 141(5):45-8. PubMed ID: 2659710 [TBL] [Abstract][Full Text] [Related]
9. [Effects of antiarrhythmic drugs on canine ventricular arrhythmia models]. Hashimoto K Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):29-39. PubMed ID: 2656435 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic drug therapy in the management of atrial fibrillation. Ganz LI; Antman EM J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1175-89. PubMed ID: 9363822 [TBL] [Abstract][Full Text] [Related]
11. [Arrhythmia and antiarrhythmic agents]. Sigurd B Nord Med; 1981 Mar; 96(3):69-71. PubMed ID: 7232116 [No Abstract] [Full Text] [Related]
12. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation]. Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950 [TBL] [Abstract][Full Text] [Related]
13. Cardiac arrhythmias and antiarrhythmic drugs: recent advances in our understanding of mechanism. Rosen MR J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):868-79. PubMed ID: 8548108 [TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic therapy and survival following myocardial infarction. Cowan JC; Coulshed DS; Zaman AG J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S92-8. PubMed ID: 1725053 [TBL] [Abstract][Full Text] [Related]
15. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110 [TBL] [Abstract][Full Text] [Related]
16. [A new group of anti-arrhythmia agents (the search, results and concept)]. Kaverina NV; Skoldinov AP Farmakol Toksikol; 1990; 53(3):26-9. PubMed ID: 2201562 [TBL] [Abstract][Full Text] [Related]
17. A consensus report on antiarrhythmic drug use. Reiffel JA; Estes NA; Waldo AL; Prystowsky EN; DiBianco R Clin Cardiol; 1994 Mar; 17(3):103-16. PubMed ID: 8168278 [TBL] [Abstract][Full Text] [Related]